X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medical and health sciences (51) 51
medicin och hälsovetenskap (51) 51
hematology (47) 47
clinical medicine (42) 42
klinisk medicin (42) 42
humans (37) 37
index medicus (37) 37
hematologi (31) 31
female (17) 17
male (17) 17
middle aged (16) 16
adult (14) 14
aged (14) 14
cancer and oncology (14) 14
cancer och onkologi (14) 14
survival (13) 13
oncology (11) 11
acute myeloid leukemia (10) 10
leukemia, myeloid, acute - mortality (9) 9
medicine (9) 9
aged, 80 and over (8) 8
leukemia, myeloid, acute - drug therapy (8) 8
medicin (8) 8
prognosis (8) 8
acute myeloid leukaemia (7) 7
animals (7) 7
leukemia, myeloid, acute - genetics (7) 7
abridged index medicus (6) 6
age (6) 6
cancer (6) 6
gene (6) 6
mutations (6) 6
survival rate (6) 6
acute disease (5) 5
adolescent (5) 5
cell biology (5) 5
chromosome aberrations (5) 5
expression (5) 5
flow cytometry (5) 5
immunohistochemistry (5) 5
leukemia, myeloid, acute - diagnosis (5) 5
registries (5) 5
remission induction (5) 5
sweden (5) 5
acute lymphoblastic leukaemia (4) 4
acute myelogenous leukemia (4) 4
acute myeloid-leukemia (4) 4
allogeneic stem cell transplantation (4) 4
aml (4) 4
autosomal trisomy (4) 4
clinical characteristics (4) 4
daunorubicin (4) 4
drug resistance (4) 4
elderly-patients (4) 4
gestational age (4) 4
heart - embryology (4) 4
journal article (4) 4
karyotype (4) 4
mutation (4) 4
nonrelapse mortality (4) 4
p53 (4) 4
performance status (4) 4
population based (4) 4
survival analysis (4) 4
treatment outcome (4) 4
age factors (3) 3
antineoplastic agents (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
article (3) 3
articles (3) 3
base sequence (3) 3
biochemistry & molecular biology (3) 3
brain - embryology (3) 3
brain - metabolism (3) 3
cell differentiation (3) 3
cell-lines (3) 3
cells (3) 3
chemosensitivity (3) 3
chitinase-3-like protein 1 (3) 3
chromosomes (3) 3
drug resistance, neoplasm (3) 3
embryonic and fetal development (3) 3
genes (3) 3
genetic aspects (3) 3
genetics (3) 3
genetics & heredity (3) 3
human (3) 3
identification (3) 3
immunophenotyping (3) 3
leukemia (3) 3
leukemia, myeloid - drug therapy (3) 3
leukemia, myeloid - pathology (3) 3
leukemia, myeloid, acute (3) 3
mice (3) 3
microscopy, confocal (3) 3
myeloid leukemia (3) 3
onkologi (3) 3
original (3) 3
pathway (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 07/2011, Volume 96, Issue 7, pp. 963 - 971
Background Patients with chromosome 5 abnormalities and high-risk myelodysplastic syndromes or acute myeloid leukemia have a poor outcome. We hypothesized that... 
Lenalidomide | Acute myeloid leukemia | Myelodysplastic syndrome | P53 mutation | DIAGNOSIS | RESPONSE CRITERIA | EFFICACY | THERAPY-RELATED MYELODYSPLASIA | AZACITIDINE | INTERNATIONAL WORKING GROUP | P53 | acute myeloid leukemia | 5Q DELETION | lenalidomide | SCORING SYSTEM | KARYOTYPE | myelodysplastic syndrome | HEMATOLOGY | WT1 Proteins - metabolism | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Oncogene Protein p21(ras) - metabolism | Tumor Suppressor Protein p53 - genetics | Thalidomide - analogs & derivatives | Antineoplastic Agents - adverse effects | Base Sequence | Aged, 80 and over | Biomarkers, Tumor - metabolism | Leukemia, Myeloid, Acute - drug therapy | Female | WT1 Proteins - genetics | Myelodysplastic Syndromes - drug therapy | Chromosomes, Human, Pair 5 - genetics | Thalidomide - adverse effects | Tumor Suppressor Protein p53 - metabolism | Treatment Outcome | Gene Expression Regulation, Leukemic | Thalidomide - administration & dosage | Mutation - genetics | Leukemia, Myeloid, Acute - mortality | Chromosome Aberrations | Myelodysplastic Syndromes - mortality | Aged | Biomarkers, Tumor - genetics | Myelodysplastic Syndromes - genetics | Leukemia, Myeloid, Acute - genetics | Oncogene Protein p21(ras) - genetics | Index Medicus | Original | Medical and Health Sciences | Hematology | Internal medicine | Medicin och hälsovetenskap | Klinisk medicin | MEDICINE | Dermatology and venerology,clinical genetics, internal medicine | Clinical Medicine | Haematology | Hematologi | MEDICIN | Invärtesmedicin | Dermatologi och venerologi, klinisk genetik, invärtesmedicin
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2015, Volume 90, Issue 3, pp. 208 - 214
Journal Article
European Journal of Haematology, ISSN 0902-4441, 05/2017, Volume 98, Issue 5, pp. 493 - 500
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 08/2017, Volume 102, Issue 2, pp. 459 - 466
Human primary CMML cells produce immunosuppressive ROS that may impact on NK cell‐ and T cell‐mediated clearance of leukemic cells. Chronic myelomonocytic... 
MDS/MPN | NK cells | T cells | CMML | reactive oxygen species | ROS | Reactive oxygen species | HISTAMINERGIC REGULATION | APOPTOSIS | NATURAL-KILLER-CELLS | OXIDATIVE STRESS | FREE SURVIVAL | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | CELL BIOLOGY | CYTOTOXIC LYMPHOCYTES | REACTIVE OXYGEN METABOLITES | HEMATOLOGY | EXPRESSION | Microscopy, Confocal | Flow Cytometry | Cell Separation | Myeloid Cells - immunology | Reactive Oxygen Species - immunology | Humans | Leukemia, Myelomonocytic, Chronic - immunology | NADPH Oxidases - immunology | Immunophenotyping | Membrane Glycoproteins - immunology | NADPH Oxidase 2 | Tumor Escape - immunology | CD34 antigen | Myelomonocytic leukemia | Memory cells | CD8 antigen | Leukemia | Immune clearance | Effector cells | Poly(ADP-ribose) polymerase | Lymphocytes T | T cell receptors | NAD(P)H oxidase | Anticancer properties | Receptors | Poly(ADP-ribose) Polymerase 1 | Immunosuppression | Lymphocytes | Cell death | Chronic myelomonocytic leukemia | Memory (computers) | CYBB protein | Degranulation | Natural killer cells | Index Medicus | cell biochemistry and function | apoptosis | natural-killer-cells | reactive oxygen | Immunology | 1991 | free survival | acute myeloid-leukemia | llin p | cytotoxic lymphocytes | expression | Hematology | metabolites | Cell Biology | p29 | histaminergic regulation | Cancer and Oncology | oxidative stress | Cancer och onkologi
Journal Article
Blood Cancer Journal, ISSN 2044-5385, 2014, Volume 4, Issue 3, pp. e189 - e189
This prospective phase II study evaluated the efficacy of azacitidine (Aza) + erythropoietin (Epo) in transfusion-dependent patients with lower-risk... 
SURVIVAL | ERYTHROPOIETIN | IMPACT | ONCOLOGY | PROPOSAL | RISK MYELODYSPLASTIC SYNDROMES | ACUTE MYELOID-LEUKEMIA | MUTATIONS | ANEMIA | MODEL | G-CSF | Original
Journal Article
Cancer, ISSN 0008-543X, 09/2011, Volume 117, Issue 18, pp. 4238 - 4246
Journal Article
Journal Article
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 04/2019, pp. 1 - 8
Consolidation chemotherapy in acute myeloid leukemia (AML) aims at eradicating residual leukemic cells and mostly comprises high-dose cytarabine with or... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2019
Secondary AML (s-AML), including AML with an antecedent hematologic disorder (AHD-AML) and therapy-related AML (t-AML), constitutes a large proportion of... 
Secondary AML | Population-based | Allogeneic hematopoietic cell transplantation | Therapy-related AML
Journal Article
European Journal of Haematology, ISSN 0902-4441, 05/2015, Volume 94, Issue 5, pp. 419 - 423
Journal Article